Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2003
12/04/2003WO2003100021A2 Methods and dna constructs for high yield production of polypeptides
12/04/2003WO2003100020A2 Methods and constructs for high yield expression of clostripain
12/04/2003WO2003100015A2 Polypeptide cleavage process
12/04/2003WO2003100008A2 Neutralizing human anti-igfr antibody
12/04/2003WO2003100001A2 Claudin polypeptides, polynucleotides, and methods of making and use thereof
12/04/2003WO2003099997A2 Methods and compositions for regulation and manipulation of steroidogenesis
12/04/2003WO2003099989A2 Compositions and methods relating to breast specific genes and proteins
12/04/2003WO2003099869A1 Antibody capable of recognizing 8-nitroguanine
12/04/2003WO2003099866A1 Transformed fungi for production of recombinant proteins
12/04/2003WO2003099862A1 Export and modification of (poly)peptides in the lantibiotic way
12/04/2003WO2003099856A1 Method of artificially synthesizing proteoglycan
12/04/2003WO2003099853A2 Petide amidation process
12/04/2003WO2003099848A2 Method for universal enzymatic production of bioactive peptides
12/04/2003WO2003099847A2 Method for enzymatic production of glp-1 (7-36) amide peptides
12/04/2003WO2003099779A2 Hemipteran muscarinic receptor
12/04/2003WO2003099340A1 Novel chimeric cd154
12/04/2003WO2003099226A2 Antibody peg positional isomers, compositions comprising same, and use thereof
12/04/2003WO2003099209A2 Compositions and methods for screening and identifying anti-hcv agents
12/04/2003WO2003087356A3 Helicokinin-receptor from insects
12/04/2003WO2003083041A3 Cripto-specific antibodies
12/04/2003WO2003072736A3 Reagents and treatment methods for autoimmune diseases
12/04/2003WO2003072062A3 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
12/04/2003WO2003070981A3 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines
12/04/2003WO2003068201A3 High affinity antibody having a tcr-like specificity and use in detection and treatment
12/04/2003WO2003057179A3 Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
12/04/2003WO2003053995A3 Soybean phosphopeptide calcium and method for producing thereof
12/04/2003WO2003048328A3 Antibodies against carboxic anhydrase ix (ca ix) tumor antigen
12/04/2003WO2003045980A3 Glycopeptide remodeling using amidases
12/04/2003WO2003031462A3 Nogo receptor-mediated blockade of axonal growth
12/04/2003WO2003022879A3 Peptides mimicking a cryptic epitope of gp41 hiv-1 and antibodies directed against them
12/04/2003WO2003021273A3 Diagnosis of carcinomas
12/04/2003WO2003018798A3 G-protein coupled receptor and dna sequences thereof
12/04/2003WO2003008579A3 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby
12/04/2003WO2002102310A3 Proteins associated with cell growth, differentiation, and death
12/04/2003WO2002086090A3 Identification of essential genes of aspegillus fumigatus and methods of use
12/04/2003WO2002082077A3 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
12/04/2003WO2002081519A9 Ifn-thy fusion protein,dna coding therefore,its preparation and application
12/04/2003WO2002079468A8 A method of increasing complementarity in a heteroduplex polynucleotide
12/04/2003WO2002070708A3 Glutamate receptor modulatory proteins and nucleic acids encoding them
12/04/2003WO2002064827A3 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof
12/04/2003WO1999013818A3 Membrane virus host range mutations and their uses as vaccine substrates
12/04/2003US20030226163 Preparing trangenic cells which comprise 3-hydroxy-3-methylglutaryl CoA reductase regulatory sequences for use in expression of heterologous polypeptides; biological pest control; bioreactors
12/04/2003US20030225253 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/04/2003US20030225250 Intestinal trefoil proteins
12/04/2003US20030225025 MDA-7 proteins and methods of use thereof
12/04/2003US20030225021 Methods of inducing the expression of bone morphogenetic proteins (BMPs) and transforming growth factor-beta proteins (TGF-betas) in cells
12/04/2003US20030224982 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/04/2003US20030224508 Novel vectors and genes exhibiting increased expression
12/04/2003US20030224501 Bone morphogenic protein polynucleotides, polypeptides, and antibodies
12/04/2003US20030224491 Continuous fermentation process
12/04/2003US20030224489 Plasmid for transformation and expression of chymosin nucleotide sequences in aspergillus
12/04/2003US20030224488 Materials and methods for preparing dimeric growth factors
12/04/2003US20030224487 Novel cytokine zcytor17 ligand
12/04/2003US20030224479 Suppressor tRNA system
12/04/2003US20030224463 Using aberrant nucleotide sequence repair to diagnose and determine cancer predisposition
12/04/2003US20030224461 Nucleic acids, proteins, and antibodies
12/04/2003US20030224415 Selection free growth of host cells containing multiple integrating vectors
12/04/2003US20030224369 Reverse screening and target identification with minicells
12/04/2003US20030224358 Comprises nucleotide sequences coding membrane protein for use as anticarcinogenic/antitumor/antiinflammatory agent
12/04/2003US20030224352 Comprises lymphadenopathy viral sequences for diagnosis of aquired immuno-depressive syndromes
12/04/2003US20030224014 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
12/04/2003US20030224012 Identifying a BASB033 polypeptide or an antibody that is immunospecific for such polypeptide, present with in a biological sample form the animal suspected having meningococcus induced infections and meningitis
12/04/2003US20030224000 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
12/04/2003US20030223994 Protein ligands comprising an immunoglobulin heavy chain variable (VH) domain and an immunoglobulin light chain variable (VL) domain, wherein the proteins bind a complex comprising an MHC and a peptide, do not substantially bind the
12/04/2003US20030223992 G-protein coupled receptor ligands and methods
12/04/2003US20030223986 Methods
12/04/2003US20030223976 Control sequences of the human corin gene
12/04/2003US20030223964 Efficient expression of HIV polypeptides in a variety of cell types, including, but not limited to, mammalian, insect, and plant cells. Synthetic expression cassettes encoding the HIV Gag-containing polypeptides are described, as are uses of the
12/04/2003CA2704273A1 Mn/ca ix-antibody binding specifically to non-immunodominant epitope of mn/ca ix and uses thereof
12/04/2003CA2487351A1 Export and modification of (poly)peptides in the lantibiotic way
12/04/2003CA2487243A1 Transformed fungi for production of recombinant proteins
12/04/2003CA2486918A1 Novel chimeric cd154
12/04/2003CA2486408A1 Methods and compositions for regulation and manipulation of steroidogenesis
12/04/2003CA2486193A1 Methods of determining precise herg interactions and altering compounds based on said interactions
12/04/2003CA2485837A1 Methods and dna constructs for high yield production of polypeptides
12/04/2003CA2485835A1 Methods and dna constructs for high yield production of polypeptides
12/04/2003CA2485829A1 Methods and constructs for high yield expression of clostripain
12/04/2003CA2485737A1 Polypeptide cleavage process
12/04/2003CA2485701A1 Method for enzymatic production of glp-1 (7-36) amide peptides
12/04/2003CA2485695A1 Method for universal enzymatic production of bioactive peptides
12/04/2003CA2485648A1 Claudin polypeptides, polynucleotides, and methods of making and use thereof
12/04/2003CA2484000A1 Neutralizing human anti-igfr antibody
12/03/2003EP1367126A1 Novel vectors for animal cells and utilization thereof
12/03/2003EP1367125A1 Vectors for expression of biotinylated proteins in mammalian cells, and their use for identification of protein-nucleic acid interactions in vivo
12/03/2003EP1367123A1 Neurotonin and use thereof
12/03/2003EP1366769A1 Inhibition of lymphocyte adherence to vascular endothelium utilizing extracellular matrix receptor-ligand interaction
12/03/2003EP1366360A2 Methods for large scale protein matching
12/03/2003EP1366175A2 Multifunctional protease inhibitors and their use in treatment of disease
12/03/2003EP1366174A2 Sid polypeptides binding to pathogenic strain of the hepatitis c virus
12/03/2003EP1366165A2 G-protein coupled receptors
12/03/2003EP1366162A2 Putative proteins and nucleic acids encoding same
12/03/2003EP1366161A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof
12/03/2003EP1366158A2 Trp8, trp9 and trp10, markers for cancer
12/03/2003EP1366156A2 Osteolevin gene polymorphisms
12/03/2003EP1366152A2 G-protein coupled receptors
12/03/2003EP1366075A2 New interferon beta-like molecules
12/03/2003EP1366065A1 Echinocandin derivatives, pharmaceutical compositions containing same and use thereof as drugs
12/03/2003EP1365804A2 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent
12/03/2003EP1064306B1 Nephrin gene and protein
12/03/2003EP0859830B1 Growth of adult pancreatic islet cells with laminin 5
1 ... 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 ... 1125